See more : Sansan, Inc. (4443.T) Income Statement Analysis – Financial Results
Complete financial analysis of HITIQ Limited (HIQ.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HITIQ Limited, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Klotho Neuroscience Inc. (KLTO) Income Statement Analysis – Financial Results
- Bridgestone Corporation (BRDCF) Income Statement Analysis – Financial Results
- APPlife Digital Solutions, Inc. (ALDS) Income Statement Analysis – Financial Results
- North China Pharmaceutical Company Ltd. (600812.SS) Income Statement Analysis – Financial Results
- ARB IOT Group Limited (ARBB) Income Statement Analysis – Financial Results
HITIQ Limited (HIQ.AX)
About HITIQ Limited
HitIQ Limited engages in development and commercialization of concussion management technology in Australia. Its Nexus software provides comprehensive head impact data and analysis to make informed decisions to improve the quality of care for athletes. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform, which identifies impairments across domains, such as hand-eye coordination, memory, and decision making; and CSX that provides an easy to use, sideline concussion assessment tool, which produces a digital record that can be shared with medical professionals, family, and organizations to take coordinated athlete care. The company was incorporated in 2015 and is based in Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 4.75M | 774.26K | 619.02K | 406.68K | 40.26K |
| Cost of Revenue | 4.41M | 531.53K | 368.97K | 3.68M | 2.79M |
| Gross Profit | 334.64K | 242.73K | 250.05K | -3.28M | -2.75M |
| Gross Profit Ratio | 7.05% | 31.35% | 40.39% | -805.31% | -6,821.82% |
| Research & Development | 635.89K | 854.69K | 1.77M | 547.46K | 569.68K |
| General & Administrative | 5.80M | 5.69M | 4.65M | 4.22M | 280.87K |
| Selling & Marketing | 180.28K | 203.99K | 144.12K | 0.00 | 160.23K |
| SG&A | 2.26M | 6.73M | 4.65M | 4.22M | 441.10K |
| Other Expenses | 0.00 | 2.48M | 1.03M | 713.20K | 0.00 |
| Operating Expenses | 2.89M | 7.58M | 8.56M | 6.13M | 1.01M |
| Cost & Expenses | 7.31M | 8.11M | 8.56M | 6.13M | 3.80M |
| Interest Income | 17.33K | 19.26K | 6.43K | 1.27K | 83.90K |
| Interest Expense | 261.34K | 192.43K | 39.39K | 53.63K | 86.59K |
| Depreciation & Amortization | 400.77K | 531.53K | 368.97K | 217.86K | 207.41K |
| EBITDA | -2.54M | -4.31M | -6.54M | -4.79M | -2.32M |
| EBITDA Ratio | -53.54% | -879.32% | -1,056.37% | -1,178.16% | -8,817.33% |
| Operating Income | -2.56M | -7.34M | -6.91M | -5.01M | -3.76M |
| Operating Income Ratio | -53.91% | -947.97% | -1,115.97% | -1,231.73% | -9,332.52% |
| Total Other Income/Expenses | -644.78K | -454.70K | -391.42K | -233.08K | 1.14M |
| Income Before Tax | -3.20M | -5.04M | -6.95M | -5.06M | -2.62M |
| Income Before Tax Ratio | -67.48% | -650.60% | -1,122.34% | -1,244.92% | -6,504.94% |
| Income Tax Expense | 0.00 | -2.00 | 1.06M | 766.84K | -3.00 |
| Net Income | -3.20M | -5.04M | -6.95M | -5.06M | -2.62M |
| Net Income Ratio | -67.48% | -650.60% | -1,122.34% | -1,244.92% | -6,504.94% |
| EPS | -0.01 | -0.02 | -0.05 | -0.07 | -0.04 |
| EPS Diluted | -0.01 | -0.02 | -0.05 | -0.07 | -0.04 |
| Weighted Avg Shares Out | 347.98M | 203.46M | 132.33M | 76.59M | 61.49M |
| Weighted Avg Shares Out (Dil) | 347.98M | 203.46M | 132.42M | 76.59M | 61.49M |
Source: https://incomestatements.info
Category: Stock Reports